Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Med Virol ; 79(7): 887-94, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17516519

RESUMEN

Hepatitis A, a vaccine preventable disease, is now of transitional or intermediate endemicity in Argentina, as the epidemiologic pattern of the disease has shifted with improvements in living conditions in some parts of the country. Increase in the susceptibility of older children and adults has led to increasing disease incidence. Molecular epidemiology has played an important role in the understanding of HAV infection by identifying modes of spreading and by permitting the monitoring of changes in circulating virus brought about by prevention programs. South American isolates characterized are limited. Eighty-two sporadic and outbreak isolates from Argentina were sequenced in the VP1/2A region of HAV genome over a 9-year period. All the isolates belonged to subgenotype IA. All our sequences grouped into two big clusters. Apparently, at least two lineages have been co-circulating in the same place at the same time. Despite great genetic variability, few point amino acid changes could be deduced. Four sequences showed an Arg --> Lys substitution at 1-297 which characterized the genotype IB at the amino acid level. Many isolates carried a conservative amino acid substitution Leu --> Ile at position 42 of the 2A domain, previously described as a possible fingerprint of HAV sequences in Brazil. The other rare changes have been found before, except for a 1-277 Asn --> Ser substitution displayed in two isolates that has not been previously reported. Argentina recently implemented universal vaccination in 1-year-old children. Molecular tools would be useful in an active surveillance program.


Asunto(s)
Virus de la Hepatitis A/genética , Virus de la Hepatitis A/aislamiento & purificación , Adulto , Sustitución de Aminoácidos , Argentina/epidemiología , Secuencia de Bases , Niño , Cartilla de ADN/genética , ADN Viral/genética , Hepatitis A/epidemiología , Hepatitis A/virología , Virus de la Hepatitis A/clasificación , Humanos , Epidemiología Molecular , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteínas Estructurales Virales/genética
2.
Clin Diagn Lab Immunol ; 9(3): 693-7, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-11986279

RESUMEN

A total of 258 human sera positive for measles antibodies were divided into four different groups: group 1 contained 54 sera from children after natural measles infection (immunoglobulin M [IgM] positive, early infection phase), group 2 contained 28 sera from children after measles vaccination (IgM positive, early infection phase), group 3 contained 100 sera from healthy adults (natural long-lasting immunity), and group 4 contained 76 sera from healthy children (postvaccinal long-lasting immunity). In the early phase of infection, the percent distributions of measles virus-specific IgG isotypes were similar between natural and postvaccinal immune responses. IgG1 and IgG4 were the dominant isotypes, with mean levels of detection of 100% (natural infection) and 100% (postvaccinal) for IgG1 and 96% (natural infection) and 92% (postvaccinal) for IgG4. In comparison, the IgG4 geometric mean titer (GMT) in the early phase of natural infection was significantly higher than the IgG4 GMT detected in the postvaccinal immune response (80 versus 13; 95% confidence interval). In the memory phase, IgG2 and IgG3 responses decreased significantly in both natural infection and postvaccinal groups, while IgG1 levels were maintained. In contrast, the IgG4 postvaccinal immune response decreased strongly in the memory phase, whereas IgG4 natural long-lasting immunity remained unchanged (9 versus 86%; P < 0.05). The results obtained suggest that IgG4 isotype could be used in the early phase of infection as a quantitative marker and in long-lasting immunity as a qualitative marker to differentiate between natural and postvaccinal immune responses.


Asunto(s)
Anticuerpos Antivirales/clasificación , Inmunoglobulina G/clasificación , Vacuna Antisarampión/inmunología , Sarampión/inmunología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Antivirales/sangre , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina G/sangre , Lactante , Masculino , Sarampión/sangre , Virus del Sarampión/inmunología , Vacunación
3.
Santa Fe; Instituto Nacional de Epidemiología Emilio Coni (Santa Fé);Instituto Nacional de Epidemiología Emilio Coni; 1992. 12 p. tbls., gráfs.(Informes, LAB.IRA.1/92). (56402).
Monografía en Español | BINACIS | ID: bin-56402

Asunto(s)
Gripe Humana , Morbilidad
4.
Santa Fe; Instituto Nacional de Epidemiología Emilio Coni (Santa Fé);Instituto Nacional de Epidemiología Emilio Coni; 1992. 12 p. graf.(Informes, LAB.IRA.1/92).
Monografía en Español | BINACIS | ID: biblio-1185510

Asunto(s)
Gripe Humana , Morbilidad
5.
Santa Fe; Argentina. Instituto Nacional de Epidemiologia de Santa Fe; 1992. 12 p. Tab.(LABIRA, 1/92). (57505).
Monografía en Español | BINACIS | ID: bin-57505
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA